Most conversations about NAD+ precursor supplements centre on a single question: NMN or NR? It's the wrong question. The supplement market is full of high-dose single-ingredient capsules, but the real science points somewhere else, to formulation context, co-factor support, and dosing ratios the body can actually use. If you've tried a standalone NMN or NR product and wondered why the energy lift felt underwhelming, that's why.
Why NAD+ Precursors Are Central to Cellular Energy
What NAD+ Actually Does Inside Your Cells
NAD+ (nicotinamide adenine dinucleotide) is not a supplement trend. It's a molecule your cells cannot function without. Inside the mitochondria, your cells' energy-generating structures, NAD+ acts as an electron carrier in the electron transport chain. It shuttles electrons between reactions that ultimately produce ATP, the currency of biological energy.
Without adequate NAD+, this chain slows. Fewer electrons move. Less ATP gets made. The downstream result is exactly what you'll recognise: persistent fatigue, mental fog, and recovery that feels slower than it should. NAD+ also activates sirtuins, a family of proteins involved in DNA repair and cellular stress response, so its importance extends well beyond raw energy output.
How NAD+ Levels Decline With Age and Modern Stress
Here's the problem: NAD+ levels don't stay constant across a lifetime. Research in ageing biology has consistently shown that NAD+ concentrations in human tissue roughly halve between early adulthood and midlife, a decline that correlates with reduced mitochondrial efficiency and slower cellular repair.
Chronic sleep disruption, poor diet, alcohol, and oxidative stress all accelerate this. By the time most people notice the fatigue or fog, their cellular energy infrastructure is already running below capacity. Supplementing NAD+ precursors is a direct response to that deficit.
NMN vs NR Bioavailability: Cutting Through the Hype
The Real Differences in Absorption and Conversion
Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors, molecules the body converts into NAD+. Their pathways differ slightly. NR enters cells via nucleoside transporters and is phosphorylated to NMN inside the cell before converting to NAD+. NMN, depending on the tissue, may be dephosphorylated to NR at the cell membrane before entering, or transported directly via recently identified NMN transporters.
Clinical trials of NR supplementation have demonstrated measurable increases in whole-blood NAD+ metabolites within two to four weeks, confirming oral bioavailability is real. NMN trials show comparable results. Neither form has a decisive, replicated advantage in human studies for subjective energy outcomes, and that matters, because the NMN vs NR bioavailability debate has driven enormous marketing spend without resolving much for consumers.
Why Neither Wins on Its Own
The conversion pathway debate distracts from a more important variable: what surrounds the precursor in the formula. Whether NMN or NR reaches your cells more efficiently is a secondary concern if the enzymes and co-factors needed to complete the conversion aren't available. Both molecules are only as effective as the metabolic environment they land in. That environment is shaped by what else you're taking, and most standalone products ignore this entirely.
The Problem With Standalone NAD+ Precursor Supplements
Walk into any major retailer or search online, and the NAD+ category looks the same: 250–500 mg of NMN or NR as the sole active ingredient, with no co-factor support. That formulation pattern reflects marketing logic, not biology.
The reason megadosing fails to deliver reliable results comes down to pathway dependencies. B3 (niacin and nicotinamide) is a biosynthetic precursor that competes for the same salvage pathway as NR and NMN. Supplementing one without accounting for the others can create an imbalance rather than a boost, a finding consistently noted by researchers studying NAD+ biology. Flooding the salvage pathway with a single precursor doesn't guarantee more NAD+; it can simply create a bottleneck at the next enzymatic step.
Beyond B3, the conversion process requires B6 and B12 as enzymatic co-factors. Magnesium is essential for hundreds of ATP-dependent reactions, including those downstream of NAD+. If any of these are limiting, a 500 mg dose of NMN provides diminishing returns, you're pushing more substrate into a pathway that lacks the tools to process it. The result: expensive urine and a supplement that underdelivers.
How a NAD+ Multivitamin Formula Changes the Equation
Co-Factors That Amplify Nicotinamide Riboside Dosing
An integrated NAD+ multivitamin formula starts from a different premise: the goal is conversion efficiency, not milligram count. By pairing NAD+ precursors with the co-factors that govern their metabolism, B3, B6, B12, and magnesium, the formulation removes the bottlenecks that megadose standalone products create.
Nicotinamide riboside dosing in a complete formula can therefore be lower than in a standalone product while delivering more usable NAD+. The co-factors aren't padding; they're functional. B6 supports aminotransferase reactions across the NAD+ biosynthesis network. B12 is essential for the methylation reactions that prevent nicotinamide from accumulating and inhibiting the sirtuins NAD+ is supposed to activate. Magnesium enables the phosphorylation steps that move precursors through the conversion chain.
Mitochondrial Function Vitamins That Work Synergistically
The case for integration extends beyond the NAD+ pathway itself. Mitochondrial function vitamins like CoQ10 and alpha-lipoic acid address the machinery that NAD+ feeds. CoQ10 operates directly in the electron transport chain, the same chain where NAD+ donates electrons for ATP production. If CoQ10 is depleted (as it often is with age or statin use), the downstream capacity for ATP synthesis is limited regardless of NAD+ availability.
Alpha-lipoic acid acts as a mitochondrial antioxidant, reducing the oxidative damage that degrades mitochondrial membranes over time. Together, these cellular energy supplements address energy production from multiple angles simultaneously, something no single-precursor product can do. A lower dose of NR or NMN, paired with these nutrients in calibrated ratios, produces a more complete stimulus than a megadose on its own.
AI-Optimised Dosing: Smarter Than a Label Guess
Traditional supplement formulation is largely a manual process: a nutritionist reviews the literature, picks doses based on the highest-studied levels, and builds a label. The problem is that ingredient interactions are non-linear. The optimal dose of NR in the presence of CoQ10 and B6 is not the same as the optimal dose in isolation, and no human researcher can hold all those interaction curves in mind simultaneously.
AI modelling changes this. By mapping how each ingredient's bioavailability curve shifts in the presence of others, and how those interactions change across different physiological states, an AI-assisted process can arrive at ratios that manual formulation cannot compute with the same precision.
Norisia's AI-assisted formulation process does exactly this. It models the interaction between NAD+ precursors and their co-factors, including B6, B12, magnesium, and CoQ10, to arrive at dosing ratios designed to maximise conversion efficiency rather than simply maximising milligrams of any single ingredient. The result is a cellular energy supplement built around what the body can actually use, not what looks most impressive on a label.
Building Your Cellular Energy Strategy in 2026
The supplement market in 2026 is noisier than ever, but the evaluation framework is straightforward once you know what to look for.
On a supplement label, prioritise:
- A named NAD+ precursor (NR or NMN) at a moderate, evidence-informed dose, not an arbitrarily high one
- B3, B6, and B12 present as active co-factors, not token inclusions
- Magnesium in a bioavailable form (glycinate or malate, not oxide)
- Mitochondrial support nutrients: CoQ10 and ideally alpha-lipoic acid
- Transparent dosing, no proprietary blends that hide individual amounts
Red flags to walk away from:
- 500 mg+ of a single precursor with no supporting nutrients
- No mention of co-factor ratios or formulation rationale
- Claims built entirely on milligram count rather than bioavailability or synergy
- Proprietary blends with undisclosed ingredient doses
The shift from megadosing to ratio-based formulation is the real frontier of NAD+ precursor supplements. It's a shift from volume to precision, and precision is where sustainable results live.
Norisia was built around this principle from day one. If you want to understand exactly how the formula is constructed, which precursors, which co-factors, and why each ratio was chosen, see the full Norisia formula and explore the AI-modelled approach behind it.